{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:32Z","timestamp":1792782812264,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","award":["#13-2024-0014"],"award-info":[{"award-number":["#13-2024-0014"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","award":["06-2024-0348"],"award-info":[{"award-number":["06-2024-0348"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seoul National University","id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radical nephroureterectomy (RNU) remains the gold standard for high-risk upper tract urothelial carcinoma (UTUC). However, renal preservation is increasingly emphasized for patients with low-grade disease or impaired renal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the diagnostic performance of URS biopsy compared to final pathologic findings after radical nephroureterectomy and to assess the clinical implications for treatment selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials &amp; methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 913 patients who underwent radical nephroureterectomy for UTUC at a single tertiary center. Among these, 164 patients underwent preoperative URS with biopsy, and 125 had both URS grade and final pathologic grade available for concordance analysis. Diagnostic performance metrics including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and Cohen\u2019s kappa coefficient were calculated. Risk factors for undergrading were identified using multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall concordance between URS biopsy and final pathology was 82.4% (103\/125). However, marked discordance was observed in low-grade URS biopsies, with an undergrading rate of 58.6% (17\/29 cases upgraded to high-grade on final pathology). The PPV for low-grade URS biopsy was only 41.4%, whereas the PPV for high-grade URS biopsy was excellent at 94.8%. Cohen\u2019s kappa was 0.423, indicating moderate agreement. Risk factors for undergrading included age &lt;65\u00a0years (OR 2.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), renal pelvis location (OR 2.59,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037), and multifocal disease (OR 2.12,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044). Patients undergoing URS biopsy had higher bladder recurrence rates (29.8% vs. 22.3% vs. 20.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020) despite not being an independent predictor at multivariate analysis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.289).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>URS biopsy demonstrates high undergrading rates (58.6%) and low PPV (41.4%) for low-grade tumors, making it unreliable for selecting patients for kidney-sparing ablative therapies. High-grade URS biopsies reliably predict high-grade disease. Alternative risk stratification strategies are needed to safely identify candidates for nephron-sparing approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-026-13249-8","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:31:39Z","timestamp":1791559899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of ureteroscopic biopsy for upper tract urothelial carcinoma: implications for kidney-sparing therapy selection"],"prefix":"10.1007","author":[{"given":"Jungwon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungkeun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younsoo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangchul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Soo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3016-0032","authenticated-orcid":false,"given":"Sang Hun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"1","key":"13249_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ et al (2023) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol 84(1):49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013","journal-title":"Eur Urol"},{"issue":"24","key":"13249_CR2","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1001\/jama.2023.22687","volume":"330","author":"N Almassi","year":"2023","unstructured":"Almassi N, Grivas P, Kaffenberger SD et al (2023) Current management of upper tract urothelial carcinoma: a review. JAMA 330(24):2377\u20132388. https:\/\/doi.org\/10.1001\/jama.2023.22687","journal-title":"JAMA"},{"issue":"4","key":"13249_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.euf.2023.03.012","volume":"9","author":"L Villa","year":"2023","unstructured":"Villa L, Soria F, Lyrdal D et al (2023) Kidney-sparing management of upper tract urothelial carcinoma: who, how, and what to expect. Eur Urol Focus 9(4):622\u2013626. https:\/\/doi.org\/10.1016\/j.euf.2023.03.012","journal-title":"Eur Urol Focus"},{"issue":"4","key":"13249_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/end.2022.0526","volume":"37","author":"AB Katims","year":"2023","unstructured":"Katims AB, Sayyid R, Soroush M et al (2023) Segmental ureterectomy for upper tract urothelial carcinoma: a review. J Endourol 37(4):371\u2013378. https:\/\/doi.org\/10.1089\/end.2022.0526","journal-title":"J Endourol"},{"issue":"1","key":"13249_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bju.15939","volume":"132","author":"A Gallioli","year":"2023","unstructured":"Gallioli A, Territo A, Mercad\u00e9 A et al (2023) Segmental ureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies. BJU Int 132(1):14\u201326. https:\/\/doi.org\/10.1111\/bju.15939","journal-title":"BJU Int"},{"issue":"4","key":"13249_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.euf.2023.03.010","volume":"9","author":"V De Coninck","year":"2023","unstructured":"De Coninck V, Soria F, Roupr\u00eat M et al (2023) Diagnostic value of ureteroscopic biopsy in upper tract urothelial carcinoma. Eur Urol Focus 9(4):618\u2013621. https:\/\/doi.org\/10.1016\/j.euf.2023.03.010","journal-title":"Eur Urol Focus"},{"issue":"22","key":"13249_CR7","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.3390\/jcm11226618","volume":"11","author":"K Mori","year":"2022","unstructured":"Mori K, Katayama S, Laukhtina E et al (2022) Diagnostic and therapeutic ureteroscopy for upper tract urothelial carcinoma. J Clin Med 11(22):6618. https:\/\/doi.org\/10.3390\/jcm11226618","journal-title":"J Clin Med"},{"issue":"6","key":"13249_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","volume":"209","author":"JA Coleman","year":"2023","unstructured":"Coleman JA, Clark PE, Bixler BR et al (2023) Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO guideline 2023. J Urol 209(6):1071\u20131081. https:\/\/doi.org\/10.1097\/JU.0000000000003480","journal-title":"J Urol"},{"key":"13249_CR9","doi-asserted-by":"publisher","DOI":"10.14440\/bladder.2025.0006","volume":"11","author":"V Huynh","year":"2024","unstructured":"Huynh V, Abou Heidar N, Wang S et al (2024) Accuracy and limitations of ureteroscopic biopsy in the staging and grading of upper tract urothelial carcinoma. Bladder (San Franc) 11:e56. https:\/\/doi.org\/10.14440\/bladder.2025.0006","journal-title":"Bladder (San Franc)"},{"issue":"4","key":"13249_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MOU.0000000000001007","volume":"32","author":"S Buse","year":"2022","unstructured":"Buse S, Shariat SF, Soria F et al (2022) Pitfalls in the diagnosis of upper tract urothelial carcinoma. Curr Opin Urol 32(4):413\u2013419. https:\/\/doi.org\/10.1097\/MOU.0000000000001007","journal-title":"Curr Opin Urol"},{"issue":"4","key":"13249_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.euf.2021.08.006","volume":"8","author":"E Laukhtina","year":"2022","unstructured":"Laukhtina E, Mori K, D\u2019Andrea D et al (2022) Diagnostic accuracy of ureteroscopic biopsy in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis. Eur Urol Focus 8(4):982\u2013992. https:\/\/doi.org\/10.1016\/j.euf.2021.08.006","journal-title":"Eur Urol Focus"},{"issue":"6","key":"13249_CR12","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.euf.2021.11.004","volume":"8","author":"T Yanagisawa","year":"2022","unstructured":"Yanagisawa T, Hayakawa N, Kapphegyi D et al (2022) Impact of ureteroscopy before radical nephroureterectomy on intravesical recurrence: a systematic review and meta-analysis. Eur Urol Focus 8(6):1701\u20131711. https:\/\/doi.org\/10.1016\/j.euf.2021.11.004","journal-title":"Eur Urol Focus"},{"issue":"5","key":"13249_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00345-023-04359-z","volume":"41","author":"S Viguier","year":"2023","unstructured":"Viguier S, Afferi L, Abdessater M et al (2023) Correlation between preoperative ureteroscopic biopsy and final pathology of upper tract urothelial carcinoma: a multicenter study. World J Urol 41(5):1377\u20131383. https:\/\/doi.org\/10.1007\/s00345-023-04359-z","journal-title":"World J Urol"},{"issue":"4","key":"13249_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.purol.2022.01.005","volume":"32","author":"M Baboudjian","year":"2022","unstructured":"Baboudjian M, Al-Balushi K, Abdessater M et al (2022) Impact of diagnostic ureteroscopy on intravesical recurrence following radical nephroureterectomy: a systematic review and meta-analysis. Prog Urol 32(4):227\u2013235. https:\/\/doi.org\/10.1016\/j.purol.2022.01.005","journal-title":"Prog Urol"},{"key":"13249_CR15","doi-asserted-by":"publisher","first-page":"1121406","DOI":"10.3389\/fonc.2023.1121406","volume":"13","author":"R Guo","year":"2023","unstructured":"Guo R, Wang X, Zhang Y et al (2023) Diagnostic ureteroscopy prior to radical nephroureterectomy for upper tract urothelial carcinoma is associated with intravesical recurrence: a systemic review and meta-analysis. Front Oncol 13:1121406. https:\/\/doi.org\/10.3389\/fonc.2023.1121406","journal-title":"Front Oncol"},{"issue":"4","key":"13249_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/JU.0000000000003157","volume":"209","author":"EJ Margolin","year":"2023","unstructured":"Margolin EJ, Matulay JT, Li G et al (2023) Voided urine cytology in the diagnosis of upper tract urothelial carcinoma: a systematic review and meta-analysis. J Urol 209(4):662\u2013670. https:\/\/doi.org\/10.1097\/JU.0000000000003157","journal-title":"J Urol"},{"issue":"10","key":"13249_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/end.2023.0105","volume":"37","author":"W Rao","year":"2023","unstructured":"Rao W, Zhang Y, Wang X et al (2023) Diagnostic value of narrow-band imaging for upper tract urothelial carcinoma: a systematic review and meta-analysis. J Endourol 37(10):1083\u20131090. https:\/\/doi.org\/10.1089\/end.2023.0105","journal-title":"J Endourol"},{"issue":"5","key":"13249_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/end.2022.0722","volume":"37","author":"L Tzelves","year":"2023","unstructured":"Tzelves L, Julieb\u00f8-Jones P, Smyrnaios D et al (2023) Diagnostic accuracy of confocal laser endomicroscopy for upper tract urothelial carcinoma: a systematic review and meta-analysis. J Endourol 37(5):488\u2013496. https:\/\/doi.org\/10.1089\/end.2022.0722","journal-title":"J Endourol"},{"issue":"15","key":"13249_CR19","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.3390\/cancers15153958","volume":"15","author":"A Koulouris","year":"2023","unstructured":"Koulouris A, Stasinopoulos K, Tzelves L et al (2023) Liquid biopsy in upper tract urothelial carcinoma: a systematic review. Cancers (Basel) 15(15):3958. https:\/\/doi.org\/10.3390\/cancers15153958","journal-title":"Cancers (Basel)"},{"issue":"2","key":"13249_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.23736\/S2724-6051.23.05199-4","volume":"75","author":"A Veccia","year":"2023","unstructured":"Veccia A, Antonelli A (2023) Enhancing the diagnosis of upper tract urothelial carcinoma: a systematic review of new technologies. Minerva Urol Nephrol 75(2):147\u2013158. https:\/\/doi.org\/10.23736\/S2724-6051.23.05199-4","journal-title":"Minerva Urol Nephrol"},{"issue":"4","key":"13249_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/MOU.0000000000001100","volume":"33","author":"E Laukhtina","year":"2023","unstructured":"Laukhtina E, Quhal F, Mori K et al (2023) Artificial intelligence in the diagnosis and management of upper tract urothelial carcinoma: a scoping review. Curr Opin Urol 33(4):365\u2013372. https:\/\/doi.org\/10.1097\/MOU.0000000000001100","journal-title":"Curr Opin Urol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13249-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:31:41Z","timestamp":1791559901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-13249-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":21,"alternative-id":["13249"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-13249-8","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jungwon Park, Jungkeun Song, Younsoo Chung, Hyung Joon Kim, Hakmin Lee, Jong Jin Oh, Sangchul Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, and Sang Hun Song have no conflicts of interest or financial ties to disclose.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}